← Return to Postop pathology to ChatGPT & asked about BCR. Anyone done this?
DiscussionPostop pathology to ChatGPT & asked about BCR. Anyone done this?
Prostate Cancer | Last Active: Mar 4 9:14pm | Replies (36)Comment receiving replies
Replies to "I got similar advice from ChatGPT just last week (also one of the few times I've..."
Connect

@tomsaville
You did have the PSA test a little early, but I would not want to wait until February For the next test. Normally the first test after surgery is done around seven or eight weeks. At that point PSA should be undetectable. If it’s above .2 that’s a problem since there’s something hanging around besides the prostate itself. You did have clear margins so it sounds like it’s not that specific area but your first PSA is definitely a little high. A PSA test right now would be about the right time to find out whether or not you really are undetectable. That could really give you an answer as to whether you need further treatment. Waiting till February could be a mistake if your PSA is rising. Ask your doctor about getting the next test now, not in February.
It is possible you could get a PSMA pet test To see if there’s spread somewhere else in your body. If the next test is higher, the pet test would Give real useful information.
ASCO American Society of Clinical Oncology, the world's leading professional organization for cancer doctors doesn’t recommend salvage radiation at .02 but at .2 it is highly recommended.
From Ascopubs about what PSA to do salvage radiation.
≤0.2 ng/mL: Starting at this level maximizes disease control and long-term survival. Patients treated at PSA < 0.2 ng/mL achieve higher rates of undetectable post-SRT PSA (56-70%) and improved 5-year progression-free survival (62.7-75%). Delaying SRT beyond PSA ≥0.25 ng/mL increases mortality risk by ~50%.
0.2–0.5 ng/mL: Still effective, particularly for patients with low-risk features (e.g., Gleason ≤7, slow PSA doubling time). The Journal of Clinical Oncology recommends SRT before PSA exceeds 0.25 ng/mL to preserve curative potential.
0.5–1.0 ng/mL: Salvage radiation remains beneficial but may require combining with androgen deprivation therapy (ADT) for higher-risk cases.
This article discusses the above;
https://ascopost.com/news/march-2023/psa-level-at-time-of-salvage-radiation-therapy-after-radical-prostatectomy-and-risk-of-all-cause-mortality/